|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IMMUNOGEN INC, 10-Q, 2000-10-27 |
Next: IMMUNOGEN INC, S-3/A, 2000-10-27 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 19,458
<SECURITIES> 11,114
<RECEIVABLES> 5,041
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 168
<PP&E> 2,096
<DEPRECIATION> 0
<TOTAL-ASSETS> 37,876
<CURRENT-LIABILITIES> 3,892
<BONDS> 0
0
0
<COMMON> 344
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 37,876
<SALES> 0
<TOTAL-REVENUES> 1,759
<CGS> 0
<TOTAL-COSTS> 4,423
<OTHER-EXPENSES> (2)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,433)
<EPS-BASIC> (.07)
<EPS-DILUTED> (.07)
</TABLE>
|
|